Howard W. Robin

Overview

Howard W. Robin received an average of $5.9M in compensation at Nektar Therapeutics from 2007 to 2018.

Related executives

We found 17 more executives who work or worked at Nektar Therapeutics.

Jillian Thomsen

Nektar Therapeutics

Chief Accounting Officer

Gil Labrucherie

Nektar Therapeutics

Chief Financial Officer

Stephen Doberstein

Nektar Therapeutics

Chief Research and Development Officer

Maninder Hora

Nektar Therapeutics

Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer

John Nicholson

Nektar Therapeutics

Chief Operating Officer

Ivan Gergel

Nektar Therapeutics

Chief Medical Officer

Rinko Ghosh

Nektar Therapeutics

Senior Vice President and Chief Business Officer

Nevan Elam

Nektar Therapeutics

Senior Vice President and Head of the Pulmonary Business Unit

News

You may also like